Skip to content

Clinical trials

Terminated Immunoblastic Lymphadenopathy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoblastic Lymphadenopathy Status: Terminated Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20042
20054
20063
20072
20085
20094
20102
20111
20122
20132
20151
20171
20182

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated36

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)7
City of Hope Medical Center4
Barbara Ann Karmanos Cancer Institute3
Fred Hutchinson Cancer Center2
M.D. Anderson Cancer Center2
Northside Hospital, Inc.2
University of Medicine and Dentistry of New Jersey2
Astex Pharmaceuticals, Inc.1
Autolus Limited1
Brian Hill, MD, PhD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoblastic Lymphadenopathy36
Lymphoma, Large-Cell, Anaplastic32
Leukemia, Lymphocytic, Chronic, B-Cell28
Lymphoma, Large B-Cell, Diffuse28
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma28
Lymphoma, Follicular26
Lymphoma, T-Cell, Cutaneous26
Mycosis Fungoides26
Lymphoma, B-Cell, Marginal Zone25
Lymphoma, Mantle-Cell25

Trials

Showing 51 to 36 of 36. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.